HUMAN MESANGIAL CELLS ARE RESISTANT TO PRODUCTIVE INFECTION BY MULTIPLE STRAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2

被引:44
|
作者
ALPERS, CE
MCCLURE, J
BURSTEN, SL
机构
[1] UNIV WASHINGTON, SCH MED, DEPT MED, SEATTLE, WA 98195 USA
[2] VET ADM MED CTR, SEATTLE, WA 98108 USA
[3] BRISTOL MYERS SQUIBB PHARMACEUT RES INST, SEATTLE, WA USA
关键词
HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED NEPHROPATHY; MESANGIAL CELLS;
D O I
10.1016/S0272-6386(12)70120-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Human immunodeficiency virus-associated nephropathy (HIVAN) is a recognized clinical entity of unknown pathogenesis. A role for viral infection of renal cells in the initiation of this process at present is an intriguing but untested hypothesis. Studies in primate models of acquired immunodeficiency syndrome (AIDS) suggest that injury to the mesangial cell may be central to the sclerosing glomerular lesion characteristic of HIVAN. We therefore tested the infectibility of human mesangial cells (HMC) in vitro by a variety of strains of HIV chosen to include a spectrum of tropisms for different cell types. Productive infection of mesangial cells could not be demonstrated using any of the virus strains. Nonetheless, HIV infection of intrinsic renal cells remains an attractive area of inquiry for understanding the natural history of HIVAN. © 1992, National Kidney Foundation. All rights reserved. All rights reserved.
引用
收藏
页码:126 / 130
页数:5
相关论文
共 50 条
  • [31] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION OF ENDOTHELIAL-CELLS INVITRO
    RE, MC
    FURLINI, G
    CENACCHI, G
    PREDA, P
    LAPLACA, M
    MICROBIOLOGICA, 1991, 14 (02): : 149 - 152
  • [32] A NOVEL ENZYME-IMMUNOASSAY FOR ANTIBODIES TO HUMAN-IMMUNODEFICIENCY-VIRUS, TYPE-1 AND TYPE-2
    FREELEY, P
    WONG, P
    WHITELEY, G
    CONTE, K
    DRAYLYONS, K
    DESPLAINES, K
    METZMANN, E
    CLINICAL CHEMISTRY, 1990, 36 (06) : 1091 - 1091
  • [33] THE EFFECTS OF CYSTEINE MUTATIONS ON THE REVERSE TRANSCRIPTASES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2
    HIZI, A
    SHAHARABANY, M
    TAL, R
    HUGHES, SH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (02) : 1293 - 1297
  • [34] COMPARATIVE-ANALYSIS OF REV FUNCTION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2
    GARRETT, ED
    CULLEN, BR
    JOURNAL OF VIROLOGY, 1992, 66 (07) : 4288 - 4294
  • [35] EVALUATION OF RAPID TEST FOR DETECTION OF ANTIBODY TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2
    ASIHENE, PJ
    KLINE, RL
    MOSS, MW
    CARELLA, AV
    QUINN, TC
    JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (05) : 1341 - 1342
  • [36] REQUIREMENT OF ACTIVE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INTEGRASE ENZYME FOR PRODUCTIVE INFECTION OF HUMAN T-LYMPHOID CELLS
    LAFEMINA, RL
    SCHNEIDER, CL
    ROBBINS, HL
    CALLAHAN, PL
    LEGROW, K
    ROTH, E
    SCHLEIF, WA
    EMINI, EA
    JOURNAL OF VIROLOGY, 1992, 66 (12) : 7414 - 7419
  • [37] MODULATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION OF HUMAN MONOCYTES BY IGA
    JANOFF, EN
    WAHL, SM
    THOMAS, K
    SMITH, PD
    JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (03): : 855 - 858
  • [38] MORPHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CHATTERJEE, S
    BASAK, S
    KHAN, NC
    PATHOBIOLOGY, 1992, 60 (04) : 181 - 186
  • [39] RADIOSENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CONWAY, B
    TOMFORD, WW
    CLINICAL INFECTIOUS DISEASES, 1992, 14 (04) : 978 - 979
  • [40] VARIANTS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    TOURNIER, JN
    VERRIER, B
    BIRON, FF
    MANDRAND, B
    PEYRAMOND, D
    MEDECINE ET MALADIES INFECTIEUSES, 1995, 25 (05): : 709 - 715